Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2003 | 04-2003 | 01-2003 | 10-2002 | 07-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,000 | -70,900 | -41,500 | -980,200 | -763,100 |
| Depreciation Amortization | 43,100 | 33,500 | 15,300 | 100,800 | 119,700 |
| Income taxes - deferred | N/A | N/A | N/A | 498,100 | 474,100 |
| Accounts receivable | 33,500 | 2,600 | 24,100 | 106,000 | 126,900 |
| Accounts payable and accrued liabilities | -37,300 | -30,000 | -17,400 | -77,100 | -80,200 |
| Other Working Capital | 51,200 | 23,200 | 61,200 | 15,700 | 128,200 |
| Other Operating Activity | 27,600 | 49,900 | 8,500 | 396,400 | 159,400 |
| Operating Cash Flow | $32,100 | $8,300 | $50,200 | $59,700 | $165,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65,500 | -16,100 | -5,700 | -25,600 | -30,100 |
| Net Acquisitions | 500 | 500 | 500 | -1,900 | -3,200 |
| Sale Of Investment | 3,700 | 4,000 | 4,000 | 70,900 | 65,700 |
| Other Investing Activity | 154,500 | 114,800 | 34,500 | -177,000 | -276,500 |
| Investing Cash Flow | $93,200 | $103,200 | $33,300 | $-133,600 | $-244,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,100 | -5,200 | -4,100 |
| Debt Repayment | 371,500 | -18,400 | N/A | N/A | N/A |
| Common Stock Issued | -31,700 | 2,800 | 300 | 9,100 | 6,500 |
| Financing Cash Flow | $339,800 | $-15,600 | $3,400 | $3,900 | $2,400 |
| Exchange Rate Effect | -300 | -300 | 500 | 200 | -100 |
| Beginning Cash Position | 278,900 | 277,700 | 278,900 | 347,500 | 348,600 |
| End Cash Position | 743,700 | 373,300 | 366,300 | 277,700 | 271,800 |
| Net Cash Flow | $464,800 | $95,600 | $87,400 | $-69,800 | $-76,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 32,100 | 8,300 | 50,200 | 59,700 | 165,000 |
| Capital Expenditure | -65,500 | -16,100 | -5,700 | -25,600 | -30,100 |
| Free Cash Flow | -33,400 | -7,800 | 44,500 | 34,100 | 134,900 |